Patient with Brain Tumor Responds Dramatically to Targeted Therapy



A patient with a papillary craniopharyngioma saw his tumor shrink more than 80 percent after treatment with a targeted drug that inhibits a mutant form of the BRAF protein.



Source link

Comments are closed.